Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)

BACKGROUND: Many people living with HIV struggle to consistently adhere to antiretroviral therapy, fail to achieve long-term virologic control and remain at risk for HIV-related disease progression, development of resistance and may transmit HIV infection to others. OBJECTIVE: To determine if switch...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Marina B, Young, Jim, Ortiz-Paredes, David, Wang, Shouao, Walmsley, Sharon, Wong, Alexander, Martel-Laferrière, Valérie, Pick, Neora, Conway, Brian, Angel, Jonathan, Baril, Jean-Guy, Fraser, Chris, Lebouché, Bertrand, Tan, Darrell H S, Sandre, Roger, Trottier, Sylvie, Peiris, Hansi, Jayaraman, Jayamarx, Singer, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759014/
https://www.ncbi.nlm.nih.gov/pubmed/36536672
http://dx.doi.org/10.2147/PPA.S379065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759014/
https://www.ncbi.nlm.nih.gov/pubmed/36536672
http://dx.doi.org/10.2147/PPA.S379065

Ejemplares similares